Cargando…
Cancer based pharmacogenomics network supported with scientific evidences: from the view of drug repurposing
BACKGROUND: Pharmacogenomics (PGx) as an emerging field, is poised to change the way we practice medicine and deliver health care by customizing drug therapies on the basis of each patient’s genetic makeup. A large volume of PGx data including information among drugs, genes, and single nucleotide po...
Autores principales: | Wang, Liwei, Liu, Hongfang, Chute, Christopher G, Zhu, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345035/ https://www.ncbi.nlm.nih.gov/pubmed/25729430 http://dx.doi.org/10.1186/s13040-015-0042-8 |
Ejemplares similares
-
A Framework of Knowledge Integration and Discovery for Supporting Pharmacogenomics Target Predication of Adverse Drug Events: A Case Study of Drug-Induced Long QT Syndrome
por: Jiang, Guoqian, et al.
Publicado: (2013) -
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020) -
Using Clinical Element Models for Pharmacogenomic Study Data Standardization
por: Zhu, Qian, et al.
Publicado: ( 201) -
In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data
por: Das, Shaoli, et al.
Publicado: (2020) -
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
por: Badary, Osama A.
Publicado: (2021)